Frequently Asked Questions
If a woman is young, healthy, has patent fallopian tubes, and her partner has a good spermiogram, a low AMH level may not pose a significant issue when trying to conceive in the present. However, it may indicate a potential concern for the future. Conversely, in women of advanced reproductive age, very low AMH levels represent an extremely low oocyte count, leading to very low success rates even with IVF. Unfortunately, there is an assumption that the oocytes will also be of reduced quality.
We frequently encounter the phenomenon of overusing vitamins and nutritional supplements among women planning a pregnancy or who are currently pregnant. Often, they combine several supplements simultaneously, which actually increases the risk of doing more harm than good. Excessive vitamin intake is not recommended; it is far more natural to maintain a sufficiently varied diet, engage in regular outdoor exercise, and get adequate sleep. If you choose to take
dietary supplements, under no circumstances should you exceed the recommended daily dose.
IVF (In Vitro Fertilization) – After the ejaculate is processed and the highest-quality spermatozoa are selected, the oocytes are fertilized in a specialized fertilization medium. Fertilization occurs spontaneously, following a principle similar to natural conception.
ICSI (Intracytoplasmic Sperm Injection) – The embryologist selects a single spermatozoon, draws it into a micropipette, and injects it directly into the cytoplasm of the oocyte.
The prices of individual procedures depend on the patient’s age, state of health, individual needs and type of treatment. We will be happy to provide you with detailed information on individual treatments based on your requirements. Contact us by filling out this form or by e-mail at info@spln.eu.
PRP (Platelet-Rich Plasma) is concentrated autologous blood plasma rich in platelets, which activate the body’s natural repair mechanisms. Platelets contain a full
spectrum of growth factors that promote tissue growth and regeneration. It is administered in two ways:
- Into the uterus enriched with hyaluronic acid (which significantly enhances its efficacy) via a catheter without requiring anesthesia.
- Into the ovaries under short general anesthesia, where it promotes tissue regeneration and restores follicle development. This is also referred to as “ovarian
rejuvenation.”
The ERA test (Endometrial Receptivity Analysis) is used to determine the window of implantation—the precise time when the uterine lining is ready to receive an
embryo. The tissue required for testing is obtained via an endometrial biopsy. The ERA test is highly sensitive, and we recommend it for women who have experienced repeated embryo transfer failures.
If the pregnancy was without complications and you are no longer breastfeeding, we require a new hormonal profile and an ultrasound examination prior to the next transfer. Breastfeeding can often be a contraindication for embryo transfer because elevated prolactin levels can suppress ovulation, meaning a breastfeeding woman often does not have a regular cycle yet. Furthermore, preparation for transfer involves estrogens, which pass into breast milk and are not suitable for a nursing infant. If hormonal levels and ultrasound findings are normal, a new preparation cycle can begin.
We recommend 3 days of sexual abstinence to ensure a sufficient volume of ejaculate for processing. Longer abstinence is not advisable, as it can negatively affect sperm morphology and motility.
Hormone treatment stimulates the ovaries to achieve the maturation of multiple follicles. It is considered safe, as the entire process takes place under strict medical supervision. Monitoring of hormone levels and ultrasound examinations are repeated as necessary. Depending on individual ovarian response, the physician may adjust hormone dosages and duration. The duration of injections depends on the protocol type, usually lasting 8–10 days. It is therefore only a short-term process that most patients tolerate without issues.
